Literature DB >> 14962908

pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1.

Frank Rosenbauer1, Katharina Wagner, Pu Zhang, Klaus-Peter Knobeloch, Atsushi Iwama, Daniel G Tenen.   

Abstract

The transcription factor PU.1 (Spi-1) is a well-characterized regulator of myeloid and lymphoid development. However, its role in mature functional cells is poorly studied. Here we report the characterization of the novel murine gene pDP4 (PU.1 difference product 4), which is absent from fetal livers of PU.1-deficient mice. pDP4 is transcribed as a single 3.2-kb mRNA with a 1518-base pair open reading frame encoded by 5 exons on chromosome 14. pDP4 expression is strongest in small intestine and bone marrow, in which it is expressed predominately in mature neutrophils. Interestingly, however, pDP4 expression is markedly down-regulated in neutrophils of the peripheral blood and peritoneum. The pDP4 gene encodes a secreted 57-kDa glycoprotein with an olfactomedin-like C-terminus. PU.1 binds to a functional site within the pDP4 promoter, and pDP4 expression in myeloid cells is strictly dependent on PU.1 and the presence of this site. In conclusion, we have identified a novel PU.1-regulated extracellular glycoprotein of the olfactomedin-like family with a possible role in neutrophilic trafficking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962908     DOI: 10.1182/blood-2003-08-2688

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.

Authors:  Wenli Liu; Ming Yan; Yueqin Liu; Ruihong Wang; Cuiling Li; Chuxia Deng; Aparna Singh; William G Coleman; Griffin P Rodgers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Authors:  Wenli Liu; Hyun Woo Lee; Yueqin Liu; Ruihong Wang; Griffin P Rodgers
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

3.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

4.  Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils.

Authors:  Wenli Liu; Yueqin Liu; Hongzhen Li; Griffin P Rodgers
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

5.  Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Authors:  Yutaka Okuno; Gang Huang; Frank Rosenbauer; Erica K Evans; Hanna S Radomska; Hiromi Iwasaki; Koichi Akashi; Francoise Moreau-Gachelin; Youlin Li; Pu Zhang; Berthold Göttgens; Daniel G Tenen
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.

Authors:  Rajendra Karki; R K Subbarao Malireddi; Qifan Zhu; Thirumala-Devi Kanneganti
Journal:  Cell Cycle       Date:  2017-06-09       Impact factor: 4.534

Review 7.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 8.  Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.

Authors:  Stanislav I Tomarev; Naoki Nakaya
Journal:  Mol Neurobiol       Date:  2009-06-26       Impact factor: 5.590

9.  The olfactomedin-4 positive neutrophil has a role in murine intestinal ischemia/reperfusion injury.

Authors:  Nick C Levinsky; Jaya Mallela; Amy M Opoka; Kelli Harmon; Hannah V Lewis; Basilia Zingarelli; Hector R Wong; Matthew N Alder
Journal:  FASEB J       Date:  2019-10-08       Impact factor: 5.834

10.  Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events.

Authors:  Vafa Shahabi; David Berman; Scott D Chasalow; Lisu Wang; Zenta Tsuchihashi; Beihong Hu; Lisa Panting; Maria Jure-Kunkel; Rui-Ru Ji
Journal:  J Transl Med       Date:  2013-03-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.